ICOS and neoplasm: Importantly, the Treg population in the tumor had, overall, a CD44hiCD62L– effector phenotype (Supplemental Figure 2D), but given the low levels of ICOS and CTLA-4 and the lack of proliferation, they clustered as cTregs (Supplemental Figure 2, B–D).